Affiliation:
1. School of Rehabilitation Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China
2. The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
Abstract
Objective:
To systematically evaluate the effects of lead therapies on percutaneous coronary intervention (PCI) after acute myocardial infarction (AMI).
Methods:
A randomized controlled trial (RCT) in the CNKI, Wanfang, VIP, ProQuest, PubMed, Cochrane Library, Scopus, and Web of Science databases was searched until January 2023. Two researchers strictly screened and checked the included literature, extracted relevant data, and used the Cochrane Manual to assess the risk quality of the literature. Using RevMan 5.3 software, Meta-analysis of 4 main outcome measures [cardiac function-related indicators, 6-minute walking distance (6 MWT), quality of life (SF-36), Seattle angina pectoris scale (SAQ)], and 3 secondary outcome measures [adverse event incidence, death incidence, and readmission rate].
Results:
22 studies were finally included with 1754 subjects, but the overall quality of the included studies was not high. The results of the meta-analysis showed that, in the cardiac function-related indicators compared to controls, improved left ventricular ejection fraction (LVEF) index (MD = 1.42, 95%CI [−0.94, 3.79], P < .00001); however, compared with the Baduanjin group, Tai Chi ball + Baduanjin group and control group, there was no significant difference (P > .05); compared with the control group, the guidance therapy group improved the left ventricular end-diastolic volume (LVEDV) index (MD = −4.67, 95%CI [−6.8, −2.71], P < .00001). In comparison, the lead group improved the 6 MWT (MD = 69.44, 95%CI [30.12, 108.76], P < .00001); the SF-36 score (MD = 10.05, 95%CI [8.68, 11.42], P < .00001])and the SAQ score (MD = 6.2, 95%CI [3.97, 8.44], P < .00001). Among the secondary outcome measures, the incidence of adverse events was statistically significant (RR = 0.17, 95%CI [0.1, 0.32], P < .00001); statistically significant (RR = 0.29, 95%CI (0.1, 0.87), P < .00001); readmission (RR = 0.39, 95%CI [0.17, 0.87, 0.89], P < .00001).
Conclusion:
Based on the current study, combining conventional therapy/ exercise or using simple lead therapy after PCI can improve the treatment effect and improve the quality of life.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference36 articles.
1. Development of MACE and their risk factors after PCI treatment in elderly patients with multimorbidity complicated by acute myocardial infarction.;Li;Chinese J Gerontol,2022
2. Progress in TCM treatment and research of acute myocardial infarction Chinese Journal of Evidence-based Cardiovascular Medicine, 2022,14 (04): 504-506 Wei Na, Zhu Meng Effect of stage I cardiac rehabilitation combined with PCI in patients with acute myocardial infarction.;Li;Mod Med Health,2023
3. Effect of amiodarone combined with metoprolol in patients with acute myocardial infarction complicated with arrhythmia and its effect on patient cardiac function Chinese.;Lian;J Chinese folk therapy,2019
4. Efficacy of emergency PCI combined with intracoronary thrombus aspiration in acute myocardial infarction.;Xu;J Hunan Normal Univ (Medical edition),2021
5. Clinical effect of postthrombolysis in transit PCI and direct PCI for acute ST-segment elevation myocardial infarction.;Feng;J Integr TCM Western Med Cardiovasc Cerebrovasc Dis,2021